Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 98
Filter
1.
J Law Med ; 31(1): 201-209, 2024 May.
Article in English | MEDLINE | ID: mdl-38761397

ABSTRACT

Illegal trafficking of narcotics and problems associated with illegal substance abuse have attracted great deal of attention over the years. However, there are concerns about how to solve this problem while still respecting individual rights. In general terms, it has been alleged by numerous international observers that in many instances human rights have not been fully respected or observed in the fight against illicit drugs. When it comes to Shari'a law, the fundamental premise is that narcotics abuse and trafficking is clearly in violation of Islamic principles. This article highlights the importance of adopting a human rights-based approach to policies regarding narcotics and discusses the potential conflict and the State's obligation to enforce laws which protect their citizens with individual citizen's rights. It focuses on Islamic laws and takes Saudi Arabia as an example given the fact that the Saudi Arabia bases its constitution on Sharia.


Subject(s)
Drug and Narcotic Control , Human Rights , Islam , Humans , Human Rights/legislation & jurisprudence , Saudi Arabia , Drug and Narcotic Control/legislation & jurisprudence , Drug Trafficking/legislation & jurisprudence
2.
Law Hum Behav ; 45(3): 215-228, 2021 06.
Article in English | MEDLINE | ID: mdl-34351204

ABSTRACT

OBJECTIVE: The present study integrates several distinct lines of jury decision-making research by examining how the racial identities of the defendant and an informant witness interact in a federal drug conspiracy trial scenario and by assessing whether jurors' individual racial identity and jury group racial composition influence their judgments. HYPOTHESES: We predicted that jurors would be biased against the Black defendant and would be more likely to convict after exposure to a White informant, among other hypotheses. METHOD: We recruited 822 nonstudent jury-eligible participants assigned to 144 jury groups. Each group was assigned to one of four onditions where defendant race (Black or White) and informant race (Black or White) was manipulated. Each group watched a realistic audio-visual trial presentation, then deliberated as a group to render a verdict. RESULTS: Contrary to expectations, the conditions depicting a Black defendant yielded lower conviction rates compared to those with a White defendant-at both the predeliberation individual (odds ratio [OR] = 1.54) and postdeliberation group level (OR = 2.91)-while the informant race did not influence verdict outcomes. We also found that jurors rated the government witnesses as more credible when the defendant was White compared to when he was Black. Credibility ratings and verdict outcomes were also predicted by jurors' own race, although juror race did not interact with the race conditions when predicting verdicts. CONCLUSIONS: Jurors are sensitive to defendant race, and this sensitivity appears to strengthen after deliberation-but in a direction opposite to what was expected. One potential implication of our findings is that juries may operate as a check on system bias by applying greater scrutiny to law enforcement-derived evidence when the defendant is Black. (PsycInfo Database Record (c) 2021 APA, all rights reserved).


Subject(s)
Decision Making , Drug Trafficking/legislation & jurisprudence , Judgment , Judicial Role , Race Factors , Racism/psychology , Adult , Aged , Aged, 80 and over , Black People , Criminal Law , Female , Humans , Law Enforcement , Male , Middle Aged , White People
3.
Ann Ist Super Sanita ; 56(1): 76-89, 2020.
Article in English | MEDLINE | ID: mdl-32242539

ABSTRACT

The penalty system implemented by Italian law still represents a barrier against psychoactive drugs and drug addiction, especially at a time when the age of first consumption has considerably dropped. Presidential Decree n. 309 of October 9, 1990 entitled "Consolidation of the laws governing drugs and psychotropic substances, the prevention, treatment and rehabilitation of drug addicts", and referred to as Presidential Decree 309/90, is the reference text for the cultivation, production, trade and use of narcotics and other psychoactive substances in Italy. The Presidential Decree has its origins in the now-forgotten law of December 22, 1975, n. 685, amended by law 162/90, which provided a draft of the current Presidential Decree 309/90. The current text has been amended numerous times over the years.


Subject(s)
Drug and Narcotic Control , Illicit Drugs/legislation & jurisprudence , Psychotropic Drugs , Analgesics/therapeutic use , Analgesics, Opioid/therapeutic use , Cannabinoids/therapeutic use , Drug Trafficking/legislation & jurisprudence , Drug Users/legislation & jurisprudence , Hazardous Waste , Health Services Accessibility/legislation & jurisprudence , Humans , Italy/epidemiology , Medical Marijuana/therapeutic use , Narcotics , Pain Management , Palliative Care/legislation & jurisprudence , Psychotropic Drugs/classification , Psychotropic Drugs/therapeutic use , Substance-Related Disorders/psychology , Substance-Related Disorders/rehabilitation
4.
Sci Eng Ethics ; 26(1): 89-120, 2020 02.
Article in English | MEDLINE | ID: mdl-30767109

ABSTRACT

Artificial intelligence (AI) research and regulation seek to balance the benefits of innovation against any potential harms and disruption. However, one unintended consequence of the recent surge in AI research is the potential re-orientation of AI technologies to facilitate criminal acts, term in this article AI-Crime (AIC). AIC is theoretically feasible thanks to published experiments in automating fraud targeted at social media users, as well as demonstrations of AI-driven manipulation of simulated markets. However, because AIC is still a relatively young and inherently interdisciplinary area-spanning socio-legal studies to formal science-there is little certainty of what an AIC future might look like. This article offers the first systematic, interdisciplinary literature analysis of the foreseeable threats of AIC, providing ethicists, policy-makers, and law enforcement organisations with a synthesis of the current problems, and a possible solution space.


Subject(s)
Artificial Intelligence/trends , Crime/trends , Social Media , Commerce/legislation & jurisprudence , Commerce/trends , Drug Trafficking/legislation & jurisprudence , Drug Trafficking/trends , Forecasting , Fraud/legislation & jurisprudence , Fraud/trends , Humans , Interdisciplinary Research , Liability, Legal , Sex Offenses/legislation & jurisprudence , Sex Offenses/trends
5.
Early Interv Psychiatry ; 14(1): 53-60, 2020 02.
Article in English | MEDLINE | ID: mdl-30945460

ABSTRACT

AIM: New psychoactive substance (NPS) use can negatively impact mental health and may result in drug-related psychiatric admissions (DRPA). Irish youth reported very high rates of NPS use by international standards, the most common being synthetic cannabinoids and cathinones. This occurred in the context of a rapid expansion in specialist high street shops, called head shops, selling NPS in 2010. Government responded to public protests about head shops by enacting legislation in May and August 2010 to end this trade. Many academics argued that such actions were futile. We sought to determine if changes in head shop activity coincided with changes in DRPA. METHOD: The national database on psychiatric admissions was examined focusing on young adults admitted from 2008 to 2012. Joinpoint regression analysis was utilized to examine for the presence of trend changes in DRPA. RESULTS: The monthly rate of DRPA was higher in 2010 than 2008, 2009 and 2012 (P < 0.01). Joinpoint regression analysis identified a significant downward trend change which occurred in July 2010 (95% CI Feb 2010 to April 2011). Young males aged 18 to 24 years showed evidence of greatest change, DRPA falling by 1.4% per month (95% CI 0.7 to 3.7% decline) from May 2010 to December 2012. CONCLUSIONS: Cessation of NPS sale by head shops coincided with a reversal in the upward trend of DRPA, this change being most evident in young men. While correlation does not imply causation, legislation which successfully targets the sale of NPS may result in reduced drug-related mental disorders.


Subject(s)
Drug Trafficking/legislation & jurisprudence , Drug Trafficking/statistics & numerical data , Hospitals, Psychiatric/statistics & numerical data , Illicit Drugs/legislation & jurisprudence , Illicit Drugs/supply & distribution , Patient Admission/statistics & numerical data , Psychotropic Drugs/adverse effects , Psychotropic Drugs/supply & distribution , Substance-Related Disorders/epidemiology , Adolescent , Adult , Databases as Topic , Databases, Factual , Drug Trafficking/prevention & control , Female , Hospitalization , Humans , Illicit Drugs/adverse effects , Male , Patient Admission/trends , Substance-Related Disorders/prevention & control , Young Adult
7.
Ann Ig ; 31(6): 626-641, 2019.
Article in English | MEDLINE | ID: mdl-31616906

ABSTRACT

When planning actions to prevent doping in the general population, public health operators may collide against the interests of criminal organizations involved in illicit trafficking of drugs. In addition to technical and professional expertise, or clinical and pharmacological skills, also a deep knowledge of legal and social issues is strongly required to face the problem and assure the effectiveness of the preventive actions. Sports competitions, athletes training or adapted physical activity may all represent conditions and environments at risk for misusing or abusing drugs and dietary supplements. A correct approach to sport and physical activity implies respect of competition rules, attention to own body limits and knowledge of risk factors. Health education campaigns and preventive actions should also consider education to legality in the different settings. The comprehension of the complex net that is available to access doping, locally or globally through online Internet sites, is essential as well as the awareness of the huge economic burden of crime interests behind the illicit trafficking of drugs. A modern whole rounded approach needs to consider doping not only as a violation of sport rules but also of the own body health, representing almost a form of addiction involving individuals and communities, and being supported by crime. Within this frame, doping is considered not just as a sport violation or a risk factor for individual's health, but as a disease of the society, in the society, against the society. A peculiar equilibrium seems to prevail between crime external pressures and resigned internal acceptance, according to the 'mafia hypothesis' model, where hosts accept parasitism to avoid retaliation. Here, main contributes and topics from the Erice 53rd Course are summarized and reviewed, providing links and references for further studies in the field. Health education and education to legality represent two sides of a same question, concerning both the general population and the health authorities. In conclusion, education to legality is a key component for prevention of doping and a priority for public health operators involved in protecting population health.


Subject(s)
Doping in Sports/prevention & control , Drug Trafficking/prevention & control , Health Education/methods , Public Health , Athletes , Dietary Supplements , Doping in Sports/legislation & jurisprudence , Drug Trafficking/legislation & jurisprudence , Humans , Illicit Drugs/legislation & jurisprudence , Substance-Related Disorders/epidemiology , Substance-Related Disorders/prevention & control
8.
BMJ Open ; 9(10): e030488, 2019 10 16.
Article in English | MEDLINE | ID: mdl-31619425

ABSTRACT

BACKGROUND AND OBJECTIVES: Many low-income and middle-income countries experience problems with open drug scenes and drug-related community issues (DRCIs). These experiences occur in settings with varying levels of health and law enforcement initiatives, and accordingly a range of approaches are implemented to curb the problem. Most of the published literature stems from Western and high-income societies. With this concern, the present study aims to describe a planned project to explore DRCIs in the open drug scenes of Tehran, including its typology, and predisposing and reinforcing factors. In addition, the study attempts to investigate the perceptions with respect to the required interventions and barriers to their accessibility. METHODS: To this end, the current study focuses on the Farahzad drug scene due to its structure and the difficult access to the scene by harm reduction providers. Data collection techniques encompass field observation, indepth interview and focus group discussion. Further, semistructured interviews are conducted with people who use drugs and other key informants who are engaged at this drug scene, including business, community, voluntary and statutory stakeholders, for an average of 90 min (average of 45 min for each part of the study). Furthermore, as a complementary method, field observation is performed regarding the themes of DRCIs at this scene. Then, focus group discussions are held to further describe the themes of DRCIs as well as to explore the required interventions, for an average of 90 min. Finally, the results are evaluated using qualitative content analysis. ETHICS AND DISSEMINATION: Ethical approval for the study was obtained from the Ethics Committee of Iran University of Medical Sciences, Iran. Additionally, participants are to provide written informed consent. The findings of the study are expected to play a role in promoting the current intervention.


Subject(s)
Drug Trafficking/prevention & control , Harm Reduction , Law Enforcement , Substance-Related Disorders/prevention & control , Cities , Drug Trafficking/legislation & jurisprudence , Focus Groups , Humans , Interviews as Topic , Iran , Observation , Qualitative Research , Research Design , Risk Factors
9.
Cien Saude Colet ; 24(9): 3395-3406, 2019 Sep 09.
Article in Portuguese, English | MEDLINE | ID: mdl-31508758

ABSTRACT

INTRODUCTION: Substance use problems remain at the core of public concern in countries sharing a common culture and a distinct history like Brazil and Portugal. OBJECTIVE: To describe findings of scientific literature about the implications of drug legislation change for the care of drug users in Brazil and Portugal. METHODS: This is an integrative review of literature that considers inclusion and exclusion criteria, sample selection, analyses and categorization of 21 articles selected that were published in databases PubMed, SciELO and Biblioteca do Conhecimento on-line (B-ON) and included ordinances and laws related to the subject. RESULTS: We observed that production on the repercussions of changes of legislation on care is scarce. Alcohol and tobacco are still a matter of concern in both countries. In Portugal, concerns about heroin-related issues have declined in recent years, but opioids use prevalence rates remain well above those of Brazil. Crack-related problems are a Brazilian reality without parallel in Portugal. In both cases, some actions are in place to change the policy in favor of a reduced repressive approach, with differentiation between users and drug dealers, increased punishment of dealers and reduced punishment of drug users.


Os problemas relacionados ao uso de drogas se mantêm como foco de preocupação em países que têm uma história em comum e trajetórias distintas como Brasil e Portugal. Objetivo: descrever os achados na literatura científica sobre os impactos das mudanças na legislação sobre drogas na assistência a estas pessoas nos dois países. Método: revisão integrativa da literatura, por meio de critérios de inclusão e exclusão, seleção da amostra, análise e categorização dos estudos com a escolha de 21 artigos publicados nas bases PubMed, SciELO e Biblioteca do Conhecimento on-line, mais portarias e leis referentes ao tema. Resultados: Observa-se que é escassa a produção sobre as repercussões das mudanças da legislação para a assistência. Nos dois países, o álcool e o tabaco se mantêm como foco de preocupação. Em Portugal, a preocupação com os problemas relacionados ao uso de heroína diminuiu nos últimos anos, mas as taxas de prevalência do uso de opióides se mantêm muito acima das do Brasil. Os problemas com o crack configuram uma realidade brasileira sem paralelo em Portugal. Em ambos os casos, há iniciativas para a mudança da política em direção à diminuição da abordagem repressiva, com a diferenciação entre usuários e traficantes, o aumento da punição dos traficantes e abrandamento da punição dos usuários.


Subject(s)
Drug Users/legislation & jurisprudence , Legislation, Drug , Substance-Related Disorders/epidemiology , Brazil/epidemiology , Drug Trafficking/legislation & jurisprudence , Health Policy , Humans , Portugal/epidemiology
10.
Ciênc. Saúde Colet. (Impr.) ; 24(9): 3395-3406, set. 2019. tab, graf
Article in Portuguese | LILACS | ID: biblio-1019667

ABSTRACT

Resumo Os problemas relacionados ao uso de drogas se mantêm como foco de preocupação em países que têm uma história em comum e trajetórias distintas como Brasil e Portugal. Objetivo: descrever os achados na literatura científica sobre os impactos das mudanças na legislação sobre drogas na assistência a estas pessoas nos dois países. Método: revisão integrativa da literatura, por meio de critérios de inclusão e exclusão, seleção da amostra, análise e categorização dos estudos com a escolha de 21 artigos publicados nas bases PubMed, SciELO e Biblioteca do Conhecimento on-line, mais portarias e leis referentes ao tema. Resultados: Observa-se que é escassa a produção sobre as repercussões das mudanças da legislação para a assistência. Nos dois países, o álcool e o tabaco se mantêm como foco de preocupação. Em Portugal, a preocupação com os problemas relacionados ao uso de heroína diminuiu nos últimos anos, mas as taxas de prevalência do uso de opióides se mantêm muito acima das do Brasil. Os problemas com o crack configuram uma realidade brasileira sem paralelo em Portugal. Em ambos os casos, há iniciativas para a mudança da política em direção à diminuição da abordagem repressiva, com a diferenciação entre usuários e traficantes, o aumento da punição dos traficantes e abrandamento da punição dos usuários.


Abstract Introduction: Substance use problems remain at the core of public concern in countries sharing a common culture and a distinct history like Brazil and Portugal. Objective: To describe findings of scientific literature about the implications of drug legislation change for the care of drug users in Brazil and Portugal. Methods: This is an integrative review of literature that considers inclusion and exclusion criteria, sample selection, analyses and categorization of 21 articles selected that were published in databases PubMed, SciELO and Biblioteca do Conhecimento on-line (B-ON) and included ordinances and laws related to the subject. Results: We observed that production on the repercussions of changes of legislation on care is scarce. Alcohol and tobacco are still a matter of concern in both countries. In Portugal, concerns about heroin-related issues have declined in recent years, but opioids use prevalence rates remain well above those of Brazil. Crack-related problems are a Brazilian reality without parallel in Portugal. In both cases, some actions are in place to change the policy in favor of a reduced repressive approach, with differentiation between users and drug dealers, increased punishment of dealers and reduced punishment of drug users.


Subject(s)
Humans , Substance-Related Disorders/epidemiology , Drug Users/legislation & jurisprudence , Legislation, Drug , Portugal/epidemiology , Brazil/epidemiology , Drug Trafficking/legislation & jurisprudence , Health Policy
11.
Rev. derecho genoma hum ; (50): 161-201, ene.-jun. 2019.
Article in Spanish | IBECS | ID: ibc-191222

ABSTRACT

El presente estudio tiene por objeto examinar el Convenio sobre la falsificación de productos médicos y delitos similares que supongan una amenaza para la salud pública (Medicrime). Los estados miembros, conscientes de la amenaza que representa para la salud pública el comercio internacional de medicamentos falsificados, han aprobado diversos instrumentos para controlar la elaboración, distribución y venta de medicamentos para el consumo humano en la Unión Europea, entre los que se destaca el aprobado por el Consejo de Europa, esto es, el Convenio Medicrime, hecho en Moscú el 28 de octubre de 2011, y que entró en vigor a partir del 1 de enero de 2016. Este instrumento ha contado, desde entonces, con la firma de más de 23 países de Europa, África y Asia para quienes supone un recurso indispensable en materia penal para los estados miembros que les permitirá proteger en mejor medida la salud pública de los ciudadanos de la venta ilegal de medicamentos


The purpose of this study is to examine the Convention on Counterfeiting of Medical Products and Similar Crimes Which pose a Threat to Public Health (Medicrime). The member states, aware of the threat to public health posed by the international trade in counterfeit medicines, have adopted various instruments to control the manufacture, distribution and sale of medicines for human consumption in the European Union, including the one approved by the Council of Europe, i.e. the Medicrime Convention, done in Moscow on 28 October 2011, which entered into force on 1 January 2016. This instrument has since been signed by more than 23 countries in Europe, Africa and Asia, for which it is an indispensable resource in criminal matters for member states that will allow them to better protect the public health of citizens from the illegal sale of medicines


Subject(s)
Humans , Fraud/legislation & jurisprudence , Counterfeit Drugs , Drug and Narcotic Control/legislation & jurisprudence , Science and Technology Cooperation Agreements , Professional Misconduct/legislation & jurisprudence , Crime/legislation & jurisprudence , Drug Trafficking/legislation & jurisprudence , Safety-Based Drug Withdrawals/legislation & jurisprudence
12.
Int J Offender Ther Comp Criminol ; 63(11): 1990-2017, 2019 08.
Article in English | MEDLINE | ID: mdl-30938214

ABSTRACT

Drug courts aim to significantly address drug abuse and drug-related criminality. However, the effectiveness of drug courts varies from court to court. The variation of success demands insights regarding what is going on inside the "black box" of drug court practices. Therefore, it is necessary to evaluate to what extent drug courts are operated in adherence with guiding principles and strategies. Using a national sample and validated measures, the current article examines the "black boxes" of adult and juvenile drug courts across the country. We found that, in general, adult drug courts face less model adherence challenges in comparison with juvenile courts, which may, in part, explain why adult drug courts perform better than juvenile drug courts overall.


Subject(s)
Drug Trafficking/legislation & jurisprudence , Interdisciplinary Communication , Intersectoral Collaboration , Adolescent , Adult , Age Factors , Humans , Models, Theoretical , United States
13.
Int J Offender Ther Comp Criminol ; 63(11): 1971-1989, 2019 08.
Article in English | MEDLINE | ID: mdl-30829089

ABSTRACT

The legal systems and the judiciary in many countries have been changed and reformed, with the aim of dispensing justice quicker and more effectively. Some reforms have tried a less adversarial approach to resolving legal disputes, for example, Therapeutic Jurisprudence (TJ) and Restorative Justice (RJ). The objective of this article is to describe how institutionalized these movements are in the United States and the roles played by judges in this process. The data collection involved document analysis, observation of court-hearings, and interviews with 13 judges from several judicial areas involved in TJ and/or RJ judicial proceedings in the United States. Data analysis was undertaken using content analysis and the software NVivo. The results provide evidence that (a) these movements are in a process of divergent change implementation; (b) judges who engage with these approaches act as institutional entrepreneurs; and (c) the judges interviewed can be classified into four roles that are complementary in the promotion of TJ/RJ: promoter, author, convener, and maintainer.


Subject(s)
Institutionalization/legislation & jurisprudence , Judicial Role , Jurisprudence , Social Justice/legislation & jurisprudence , Crime/legislation & jurisprudence , Crime/prevention & control , Drug Trafficking/legislation & jurisprudence , Humans , Problem Solving , United States
14.
J Addict Nurs ; 30(1): 71-76, 2019.
Article in English | MEDLINE | ID: mdl-30830005

ABSTRACT

The purpose of this Policy Watch column is to provide a brief overview of the global problems associated with the illicit production and trafficking of synthetic opioids as well as international efforts and policy approaches designed to curb them. An in-depth evaluation of drug control efforts of many different nations is important for a comprehensive analysis. However, because of the vast amount of information available, this column is limited to cooperative global control efforts, not efforts specific to any one nation. A great deal of information about production methods, clandestine laboratories, international trafficking methods, and online sales over the dark Web has been omitted. It is important to understand key issues regarding the illicit cultivation and distribution of plant-based opioids derived from natural compounds found in opium poppies (heroin, opium, morphine, codeine) or other drugs (cocaine, methamphetamines, etc.), but the scope of this column is limited to discussion about synthetic opioids including fentanyl, fentanyl analogues, and fentanyl precursor chemicals. Issues about human rights and ethical considerations for nurses and other addictions professionals are also discussed.


Subject(s)
Analgesics, Opioid/adverse effects , Drug Trafficking/prevention & control , Drug and Narcotic Control/legislation & jurisprudence , Fentanyl/adverse effects , Global Health , International Health Regulations , Opioid-Related Disorders/prevention & control , Adolescent , Adult , Aged , Analgesics, Opioid/chemical synthesis , Drug Trafficking/legislation & jurisprudence , Female , Fentanyl/analogs & derivatives , Fentanyl/chemical synthesis , Human Rights/legislation & jurisprudence , Humans , Male , Middle Aged , Nurse's Role , Opioid-Related Disorders/nursing , Young Adult
16.
Int J Offender Ther Comp Criminol ; 62(16): 4942-4959, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30239251

ABSTRACT

Although much research has documented the fact that a high percentage of female inmates serving sentences for drug offenses have experienced domestic violence prior to incarceration, little research has been done to explore the potential long-term impact of domestic violence on prison misconduct, health status, and the need for post-release assistance. Based on survey data for 633 female drug offenders collected from Taiwanese correctional facilities in 2014, about one third (32%) of the offenders reported experienced domestic violence at least once prior to their incarceration. In all, 27% of them experienced being violently abused by a spouse/coinhabitant. Multivariate regression analyses indicate that a prior history of domestic violence victimization contributes significantly to inmates' violent misconduct even after controlling for a set of potential intervening variables. In addition, female drug offenders who were the victims of domestic violence reported higher levels of health problems in the prison setting, and perceived need for greater after-release assistance.


Subject(s)
Crime Victims , Domestic Violence , Drug Trafficking/legislation & jurisprudence , Health Status , Prisoners , Adult , Female , Humans , Needs Assessment , Surveys and Questionnaires , Taiwan
17.
J Law Med Ethics ; 46(2): 367-381, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30146989

ABSTRACT

This paper focuses on the most common state policy responses to the opioid crisis, dividing them into six broad categories. Within each category we highlight the rationale behind the group of policies within it, discuss the details and support for individual policies, and explore the research base behind them. The objective is to better understand the most prevalent state responses to the opioid crisis.


Subject(s)
Opioid-Related Disorders/therapy , Public Policy , State Government , Analgesics, Opioid/administration & dosage , Drug Prescriptions , Drug Trafficking/legislation & jurisprudence , Education, Medical, Continuing , Health Education , Humans , Legislation, Drug , Naloxone/supply & distribution , Narcotic Antagonists/supply & distribution , Needle-Exchange Programs , Opiate Substitution Treatment , Pain Management , Physicians/legislation & jurisprudence , Prescription Drug Misuse/prevention & control , Prescription Drug Monitoring Programs , United States
18.
J Law Med Ethics ; 46(2): 404-421, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30146996

ABSTRACT

While much of the social and political attention surrounding the nationwide opioid epidemic has focused on the dramatic increase in overdose deaths among white, middle-class, suburban and rural users, the impact of the epidemic in Black communities has largely been unrecognized. Though rates of opioid use at the national scale are higher for whites than they are for Blacks, rates of increase in opioid deaths have been rising more steeply among Blacks (43%) than whites (22%) over the last five years. Moreover, the rate of opioid overdose deaths among Blacks already exceeds that of whites in several states. The lack of discussion of Black overdose deaths in the national opioid discourse further marginalizes Black people, and is highly consistent with a history of framing the addictions of people of color as deserving of criminal punishment, rather than worthy of medical treatment. This article argues that, because racial inequalities are embedded in American popular and political cultures as well as in medicine, the federal and state governments should develop more culturally targeted programs to benefit Black communities in the opioid crisis. Such programs include the use of faith-based organizations to deliver substance use prevention and treatment services, the inclusion of racial impact assessments in the implementation of drug policy proposals, and the formal consideration of Black people's interaction with the criminal justice system in designing treatment options.


Subject(s)
Black or African American , Opioid-Related Disorders/ethnology , Opioid-Related Disorders/therapy , Analgesics, Opioid/adverse effects , Community Health Services/organization & administration , Drug Overdose/ethnology , Drug Overdose/mortality , Drug Trafficking/legislation & jurisprudence , Humans , Mass Media , Public Health , Social Marginalization , Synthetic Drugs/adverse effects , United States/epidemiology , White People
19.
J Law Med Ethics ; 46(2): 314-324, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30147007

ABSTRACT

This article seeks to document the latest danger in the opioid crisis: fentanyl and related synthetic opioids. Fifty times more potent than pure heroin, cheaper to manufacture in laboratories worldwide, and easily distributed by mail and couriers, fentanyl is flooding the illicit opioid markets throughout the country.


Subject(s)
Analgesics, Opioid/adverse effects , Drug Trafficking , Fentanyl/adverse effects , Illicit Drugs/adverse effects , Analgesics, Opioid/supply & distribution , Counterfeit Drugs/adverse effects , Drug Overdose , Drug Trafficking/economics , Drug Trafficking/legislation & jurisprudence , Fentanyl/analogs & derivatives , Fentanyl/supply & distribution , Humans , Illicit Drugs/supply & distribution , Internationality , Opioid-Related Disorders/epidemiology , Public Policy , United States
20.
J Law Med Ethics ; 46(2): 292-313, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30147006

ABSTRACT

This article examines how federal law enforcement has responded to the opioid epidemic nationally and in a variety of locales. We focus in depth on two initiatives, including prosecution in opioid-death cases, undertaken by the U.S. Attorney's Office in Connecticut.


Subject(s)
Analgesics, Opioid/adverse effects , Drug Overdose , Drug Trafficking/legislation & jurisprudence , Federal Government , Opioid-Related Disorders/epidemiology , Criminal Law , Humans , Physicians/legislation & jurisprudence , Substance-Related Disorders , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...